New York State Common Retirement Fund Iovance Biotherapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 72,101 shares of IOVA stock, worth $178,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,101
Previous 72,101
-0.0%
Holding current value
$178,089
Previous $124,000
25.81%
% of portfolio
0.0%
Previous 0.0%
Shares
38 transactions
Others Institutions Holding IOVA
# of Institutions
292Shares Held
219MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$59.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...